Characterization of an adduct between CC-1065 and a defined oligodeoxynucleotide duplex

Area of Science:

• Molecular Biology
• Medicinal Chemistry
• Genetics

Background:

• CC-1065 is a potent antitumor antibiotic from Streptomyces zelensis.
• It covalently binds to adenine within the DNA minor groove.
• Previous studies suggested sequence specificity and a thermally labile adduct.

Purpose of the Study:

• To synthesize a specific DNA sequence for unambiguous CC-1065 binding.
• To characterize the CC-1065-DNA adduct structure and properties.
• To investigate drug-mediated DNA strand breakage.

Main Methods:

• Chemical synthesis of a 14-mer DNA oligoduplex containing a 5 étaire-TTA-3' binding site.
• Reaction of the oligoduplex with CC-1065.
• Analysis of the resulting adduct using Circular Dichroism (CD) spectroscopy.
• 32P 5 étaire-end labeling, annealing, CC-1065 reaction, heating, and DNA sequencing gel electrophoresis.
• Piperidine treatment to assess drug-mediated strand cleavage.

Main Results:

• CC-1065 formed a B-DNA adduct with the synthesized oligoduplex, showing similar CD spectra to calf thymus DNA complexes.
• Drug-mediated heating caused a single strand break in the labeled DNA.
• Piperidine treatment yielded a 7mer fragment, consistent with CC-1065 binding to adenine in 5 étaire-TTA-3' sequences.

Conclusions:

• The synthesized DNA oligoduplex unambiguously binds CC-1065 at the 5 étaire-TTA-3' site.
• The CC-1065-DNA adduct retains B-DNA conformation.
• The study confirms CC-1065's mechanism of inducing sequence-specific DNA strand breakage.